Literature DB >> 24715853

Microdeletions including FMR1 in three female patients with intellectual disability - further delineation of the phenotype and expression studies.

A M Zink1, E Wohlleber1, H Engels1, O K Rødningen2, K Ravn3, S Heilmann4, J Rehnitz5, N Katzorke5, C Kraus6, S Blichfeldt7, P Hoffmann8, H Reutter9, F F Brockschmidt4, M Kreiß-Nachtsheim1, P H Vogt5, T E Prescott2, Z Tümer10, J A Lee11.   

Abstract

Fragile X syndrome (FXS) is one of the most common causes of intellectual disability/developmental delay (ID/DD), especially in males. It is caused most often by CGG trinucleotide repeat expansions, and less frequently by point mutations and partial or full deletions of the FMR1 gene. The wide clinical spectrum of affected females partly depends on their X-inactivation status. Only few female ID/DD patients with microdeletions including FMR1 have been reported. We describe 3 female patients with 3.5-, 4.2- and 9.2-Mb de novo microdeletions in Xq27.3-q28 containing FMR1. X-inactivation was random in all patients, yet they presented with ID/DD as well as speech delay, macrocephaly and other features attributable to FXS. No signs of autism were present. Here, we further delineate the clinical spectrum of female patients with microdeletions. FMR1 expression studies gave no evidence for an absolute threshold below which signs of FXS present. Since FMR1 expression is known to be highly variable between unrelated females, and since FMR1 mRNA levels have been suggested to be more similar among family members, we further explored the possibility of an intrafamilial effect. Interestingly, FMR1 mRNA levels in all 3 patients were significantly lower than in their respective mothers, which was shown to be specific for patients with microdeletions containing FMR1.

Entities:  

Keywords:  Expression; FMR1; Intellectual disability; Microdeletion; Xq27.3–q28

Year:  2014        PMID: 24715853      PMCID: PMC3977317          DOI: 10.1159/000357962

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  26 in total

1.  Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome.

Authors:  J T Clarke; P J Wilson; C P Morris; J J Hopwood; R I Richards; G R Sutherland; P N Ray
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

2.  Mental status of females with an FMR1 gene full mutation.

Authors:  B B de Vries; A M Wiegers; A P Smits; S Mohkamsing; H J Duivenvoorden; J P Fryns; L M Curfs; D J Halley; B A Oostra; A M van den Ouweland; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

Review 3.  Fragile X syndrome and deletions in FMR1: new case and review of the literature.

Authors:  L S Hammond; M M Macias; J C Tarleton; G Shashidhar Pai
Journal:  Am J Med Genet       Date:  1997-11-12

Review 4.  Fragile X-associated disorders: a clinical overview.

Authors:  Anne Gallagher; Brian Hallahan
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

5.  Translational suppression by trinucleotide repeat expansion at FMR1.

Authors:  Y Feng; F Zhang; L K Lokey; J L Chastain; L Lakkis; D Eberhart; S T Warren
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

6.  Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders.

Authors:  M Poot
Journal:  Mol Syndromol       Date:  2013-04-04

7.  Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.

Authors:  J T Clarke; W L Greer; P M Strasberg; R D Pearce; M A Skomorowski; P N Ray
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

8.  Skewed X-chromosome inactivation is common in fetuses or newborns associated with confined placental mosaicism.

Authors:  A W Lau; C J Brown; M Peñaherrera; S Langlois; D K Kalousek; W P Robinson
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

Review 9.  A decade of molecular studies of fragile X syndrome.

Authors:  William T O'Donnell; Stephen T Warren
Journal:  Annu Rev Neurosci       Date:  2002-03-20       Impact factor: 12.449

10.  Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.

Authors:  Eva García-Alegría; Berta Ibáñez; Mónica Mínguez; Marisa Poch; Alberto Valiente; Arantza Sanz-Parra; Cristina Martinez-Bouzas; Elena Beristain; Maria-Isabel Tejada
Journal:  RNA       Date:  2007-05       Impact factor: 4.942

View more
  4 in total

Review 1.  On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.

Authors:  Alexandra N Khristich; Sergei M Mirkin
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

2.  De Novo Large Deletion Leading to Fragile X Syndrome.

Authors:  Poonnada Jiraanont; Esther Manor; Nazi Tabatadze; Marwa Zafarullah; Guadalupe Mendoza; Gia Melikishvili; Flora Tassone
Journal:  Front Genet       Date:  2022-05-11       Impact factor: 4.772

3.  Screening for intellectual disability using high-resolution CMA technology in a retrospective cohort from Central Brazil.

Authors:  Rodrigo Roncato Pereira; Irene Plaza Pinto; Lysa Bernardes Minasi; Aldaires Vieira de Melo; Damiana Mirian da Cruz e Cunha; Alex Silva Cruz; Cristiano Luiz Ribeiro; Cláudio Carlos da Silva; Daniela de Melo e Silva; Aparecido Divino da Cruz
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

4.  Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in FMR1 and Associated Phenotypes.

Authors:  Cedrik Tekendo-Ngongang; Angela Grochowsky; Benjamin D Solomon; Sho T Yano
Journal:  Genes (Basel)       Date:  2021-10-22       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.